Twinbeech Capital LP Fulgent Genetics, Inc. Transaction History

Twinbeech Capital LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$47.98 - $62.75 $355,915 - $465,479	-7,418 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$49.85 - $96.11 $369,787 - $712,943	7,418 New	7,418 $463,000
Q2 2021 Aug 16, 2021	SELL	$66.8 - $100.45 $150,300 - $226,012	-2,250 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$59.3 - $183.85 $133,425 - $413,662	2,250 New	2,250 $217,000

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

Stay updated on Twinbeech Capital LP with notifications on news.